Active · per the CBE, 29 October 2026
QBIC III FUND logo

QBIC III FUND

BE0782842062

Rechtspersoon Limited partnership 1 establishment

Soenenspark 56, 9051 Gent qbic.be

Behind the company: QBIC Venture Partners III NV.

Active for

4 year, 7 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Two loss years in a row NBB

    Negative result in 2024 and 2025.

Financials

Financial year 2025

QBIC III FUND from Gent, company number BE0782842062, closed financial year 2025 with a result of € -1.9 million after tax. For that financial year QBIC III FUND recorded a gross margin of € -1.8 million and equity of € 38.5 million. Compared with financial year 2024, the result moved from € -1.7 million to € -1.9 million. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 5, 2026.

What it is worth Growing

€ 38.5 million

▲ 48% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -1.9 million

▼ 13 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 2.7 million

▼ 22% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -5.8 million.

People and assets in 2025

Full-time equivalents

0

Average over the fiscal year, from the social balance sheet.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,290

▲ 31% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € -832,816 € -1,479,423 € -1,799,489 € -1,802,339
Profit after taxes € -827,968 € -1,426,104 € -1,660,696 € -1,875,504 ▼ € 214,807
Equity € 4,072,032 € 15,452,178 € 25,961,781 € 38,517,070 ▲ 48%
Total debts € 2,616 € 514,786 € 983 € 1,290 ▲ 31%
Cash € 1,777,868 € 8,431,665 € 3,533,923 € 2,748,151 ▼ 22%
Retained profit € -827,968 € -2,254,072 € -3,914,768 € -5,790,271 ▼ € 1.9 million
Balance sheet total € 4,074,648 € 15,966,965 € 25,962,763 € 38,518,360 ▲ 48%

Key figures of QBIC III FUND, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to QBIC III FUND?

What happened at QBIC III FUND in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 1.9 million. Source: NBB ↗
  • New establishment in Gent. KBO
  • Start of the company according to the CBE. KBO

In short

From € 827,968 loss in 2022 to € 1.9 million loss in 2025.

Paid € 9,294 in corporate taxes since 2022.

Management

The stake of Participatiemaatschappij Vlaanderen, SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT, VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

QBIC III FUND

Behind QBIC III FUND is QBIC Venture Partners III NV. The shares are held by Participatiemaatschappij Vlaanderen (15.3%), SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT (14.1%) and VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK (0.6%). It owns 22.8% of Theratrame NV, 21.4% of Obulytix BV, 19.1% of Tanai Therapeutics NV, 17.5% of Weave.ly, 17% of RheaVita BV and 15.1% of AnimAb BV itself.

Directors

According to the 2025 annual accounts

QBIC Venture Partners III NV

Manager · represented by Sofie Baeten

Also active at: RheaVita, VoxelSensors, AnimAb, AmphiStar, weave.ly, Swave, THERAtRAME, Obulytix +2 more

Participations

Weave.ly

17.5%

AnimAb BV

15.1%

AmphiStar

12.4%

Ailos BV

11.9%

Flindr Therapeutics

11.6%

EYEO B.V.

7.6%

Establishments

Establishment units

Physical locations of this company

Registered office

Soenenspark 56

9051 Gent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

Technologies

Amazon CloudFrontCloudflare CDNGoogle FontsjQuery

Hosting & Email

Email provider

Microsoft 365

Hosting

CLOUDFLARESPECTRUM Cloudflare, Inc., US

Website info

HTTPS Ja

Features

Blog Jobs Contact page

Security

✓ HTTPS
✓ SPF
✗ DMARC

Details

Company number
0782.842.062
VAT number
BE 0782.842.062
Registered office
Soenenspark 56, 9051 Gent
Names & denominations
QBIC III FUND
Enterprise type
Rechtspersoon
Legal form
Limited partnership
Legal situation
Normale toestand
Start date
3 March 2022
Peppol
Active · Active since 21 Oct 2026
Contact
qbic.be

Frequently asked questions

What is the address of QBIC III FUND?
The registered office of QBIC III FUND is located at Soenenspark 56, 9051 Gent.
Is QBIC III FUND still active?
Yes. According to the CBE (29 October 2026) QBIC III FUND is active, legal situation “Normale toestand”, started on 3 March 2022.
Is QBIC III FUND registered on Peppol?
Yes, QBIC III FUND is registered on the Peppol network with ID 0208:0782842062.
What is the enterprise number of QBIC III FUND?
The enterprise number of QBIC III FUND is BE0782842062.
When was QBIC III FUND founded?
QBIC III FUND was founded on 3 March 2022.
Who owns QBIC III FUND?
Behind QBIC III FUND is QBIC Venture Partners III NV. The shares are held by Participatiemaatschappij Vlaanderen (15.3%), SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT (14.1%) and VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK (0.6%). It owns 22.8% of Theratrame NV, 21.4% of Obulytix BV, 19.1% of Tanai Therapeutics NV, 17.5% of Weave.ly, 17% of RheaVita BV and 15.1% of AnimAb BV itself.